Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain by Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

Get full text

The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS by Talbot, T, Dangoor, A, Shah, R, Naik, J, Talbot, D, Lester, J, Cipelli, R, Patel, A, Summerhayes, M, Newsom-Davis, T

The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study by Talbot, T, Dangoor, A, Shah, R, Naik, J, Talbot, D, Lester, JF, Cipelli, R, Hodgson, M, Patel, A, Summerhayes, M, Newsom-Davis, T